Why use it

Fetal asphyxia is associated with specific acute (breathing movements, movement, tone, NST) and chronic (amniotic fluid volume) markers. The BPP integrates both acute and chronic markers into a single score, providing a more comprehensive assessment than NST alone. Abnormal BPP scores have a high negative predictive value for fetal compromise and guide timely delivery decisions to prevent intrauterine fetal death or neonatal injury.

About

The Fetal Biophysical Profile (BPP) is a validated antepartum fetal surveillance test developed by Manning and colleagues that integrates real-time ultrasound observation with electronic fetal heart rate monitoring (non-stress test, NST) to comprehensively assess fetal wellbeing. The BPP evaluates five parameters, each scored 0 (abnormal) or 2 (normal): (1) fetal breathing movements, (2) fetal gross body movements, (3) fetal tone/posture, (4) amniotic fluid volume (AFV), and (5) non-stress test (NST) reactivity. Total score ranges from 0 to 10. A score of 8–10 is reassuring; 6 is equivocal; ≤4 is abnormal and requires prompt delivery or further evaluation. The Modified BPP (mBPP) uses only the NST and AFV assessment, which is a commonly used abbreviated version in clinical practice. The BPP is widely used from 26 weeks gestation onward for surveillance of high-risk pregnancies.

When to use

Routine antenatal surveillance in high-risk pregnancies (post-dates, IUGR, preeclampsia, diabetes, decreased fetal movement)
Assessment following a non-reactive NST to determine need for delivery
Follow-up assessment of pregnancies with oligohydramnios or polyhydramnios
Evaluation of maternal report of decreased fetal movement
Monitoring of pregnancies complicated by placental insufficiency or cord abnormalities
Post-term pregnancy surveillance (≥41 weeks gestation)

Formula

BPP Score = Sum of 5 parameters, each scored 0 or 2: 1. Fetal Breathing Movements (FBM): ≥1 episode lasting ≥30 seconds in 30 min = 2; otherwise = 0 2. Gross Body Movement (FM): ≥3 discrete body/limb movements in 30 min = 2; otherwise = 0 3. Fetal Tone (FT): ≥1 episode of active extension/flexion (limb or spine) in 30 min = 2; otherwise = 0 4. Amniotic Fluid Volume (AFV): Single vertical pocket ≥2 cm = 2; SVP <2 cm = 0 5. Non-Stress Test (NST): ≥2 accelerations of ≥15 bpm for ≥15 sec in 20 min = 2; otherwise = 0 Total 0–10: 8–10: Normal 6: Equivocal 4: Suspicious for asphyxia 0–2: Strongly abnormal — high risk of asphyxia

Pearls & pitfalls

The NST is the most sensitive acute marker of fetal oxygenation but has a high false-positive rate — combining with ultrasound parameters in the BPP reduces false positives.
Amniotic fluid volume (AFV) is a CHRONIC marker reflecting days to weeks of fetal renal perfusion — it does not change acutely with a single hypoxic episode.
Fetal breathing movements are the FIRST parameter to disappear with fetal hypoxia; fetal tone is the LAST to be lost (reflects deepest neurological centers).
A single largest vertical pocket (SVP) ≥2 cm or AFI ≥5 cm is used for normal AFV scoring; SVP <2 cm or AFI <5 cm = oligohydramnios (score 0).
The Modified BPP (NST + AFV only) has a negative predictive value >99.9% for stillbirth within 1 week and is used widely as a first-line surveillance test.
A score of 10/10 requires a reactive NST — fetal breathing ≥30 seconds of sustained movement within 30 minutes is required for a BPP score of 2.
Fetal "practice breathing" (breathing movements) are normally episodic and may be suppressed by maternal sedation, fetal sleep cycles, or hypoglycemia — allow up to 30 minutes of observation.
BPP interpretation should always be individualized with gestational age, clinical context, and overall maternal-fetal risk assessment.
Vibroacoustic stimulation (VAS) can shorten testing time in non-reactive NSTs without reducing diagnostic accuracy.

Next steps

BPP 8–10 with normal AFV: Low risk of chronic asphyxia. Routine surveillance. Repeat as per clinical indication. BPP 8 with oligohydramnios: Deliver if ≥36 weeks; if preterm, individualize management. BPP 6 (Equivocal): Repeat BPP in 4–6 hours. If still 6, individualize based on gestational age and clinical context. BPP 4: Suspected fetal compromise. Deliver if ≥32 weeks gestation. If <32 weeks, individualize; likely delivery after antenatal corticosteroids. BPP 0–2: Strongly suggestive of fetal asphyxia. Expedite delivery regardless of gestational age.

Evidence

Manning FA et al. Fetal assessment based on fetal biophysical profile scoring. Am J Obstet Gynecol. 1980;136(6):787-795. PMID:7361794. Manning FA et al. Fetal biophysical profile scoring: selective use of the nonstress test. Am J Obstet Gynecol. 1987;156(3):709-712. PMID:3826171. Large prospective study: false-negative rate (perinatal death within 1 week of BPP ≥8) = 0.6–0.7 per 1000 tested. ACOG Practice Bulletin #145 (Antepartum Fetal Surveillance) endorses BPP as a component of antepartum testing.

References

Manning FA et al. Fetal assessment based on fetal biophysical profile scoring. Am J Obstet Gynecol. 1980;136(6):787-795. — link
Manning FA et al. Fetal biophysical profile scoring: selective use of the nonstress test. Am J Obstet Gynecol. 1987;156(3):709-712. — link
ACOG Practice Bulletin No. 145: Antepartum fetal surveillance. Obstet Gynecol. 2014;124(1):182-192. — link

Fetal Biophysical Profile (BPP) Score

Calculator